EUCTR2020-002497-27-CZ进行中（未招募）1 期
A randomized, open-label, phase IV monocentric study evaluating the clinical effect of oral immunomodulatory therapy with IMUNOR® in patients with moderate COVID-19 disease
Thomayerova nemocnice0 个研究点目标入组 30 人开始时间: 2020年10月22日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Women or men aged 18 and over;
- •Documented incidence of COVID-19 disease with moderate clinical manifestations requiring hospitalization (as assessed by the attending physician);
- •The patient's ability to cooperate and sign the informed consent form;
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Use of any other immunomodulatory treatment during the last month before entering the study (bacterial lysates, immunoglucans, immunoglobulins, etc.)
- •Need for pulmonary ventilation at study entry;
- •Known hypersensitivity to the active substance;
- •Pregnancy and breast-feeding
研究者
相似试验
进行中（未招募）
不适用
A Phase IV, open label, randomized, monocentric study to evaluate immunogenicity and safety of GSK Biologicals' seasonal (2010-2011) influenza vaccine FluarixTM in adolescents previously vaccinated with GSK Biologicals' H1N1 vaccine (PandemrixTM). - FLU D-PAN H1N1-AS03-044Immunization against influenza of children previously vaccinated with GSK's adjuvanted H1N1 vaccine (PandemrixTM) at the age of 10-17 years.MedDRA version: 12.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2010-020331-39-FIGlaxoSmithKline Biologicals
进行中（未招募）
1 期
This study compares clinically and microscopically the response to two treatments, a steroid in cream and a foam that contains a steroid and a vitamin D analogue in patients with plaque psoriasis.Plaque psoriasisEUCTR2017-004451-24-ESFundació Clínic per a la Reserca Biomèdica36
进行中（未招募）
1 期
Immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids™ co-administered with GSK Biologicals’ human rotavirus (HRV) vaccine Rotarix™ (444563) in healthy infants.Active immunisation of infants against gastroenteritis (GE) due to rotavirus (RV).MedDRA version: 19.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-005282-78-Outside-EU/EEAGlaxoSmithKline Biologicals262
已完成
4 期
Clinical study to check the effectiveness and safety of AphtoFix® Mouth Ulcer Cream in subjects suffering from mouth ulcer.CTRI/2014/08/004918Bonyf AG
进行中（未招募）
不适用
A phase IV, open-label, randomized, multicenter trial assessing a reyataz-based substitution approach in the management of lipodystrophy syndrome.HIVMedDRA version: 6.1Level: PTClassification code 10049287EUCTR2004-002740-10-ITBRISTOL-M.SQUIBB300